MEMBER NEWS
Derby firm provides rapid Covid-19 tests
The Government has ordered two million of the first British- manufactured test kits to diagnose asymptomatic Covid-19 carriers – and they were made by a Chamber member. Derby-based SureScreen
Diagnostics provided the lateral flow antigen tests, which return results in under 30 minutes, to Public Health England last month. The company - which has sent its
tests, also including those detecting antibodies, across the world - has the capacity to make millions more in the coming months. David Campbell (pictured),
director of SureScreen, said: “We believe our rapid antigen tests can really help in screening people both in the community and in clinical settings. Routine testing is crucial to help business and schools as well as hospitals and GPs. “We are delighted to be working
The lateral flow tests will be an important part of asymptomatic testing activity
with the Department of Health and Social Care on this project and that our tests have been recognised by the Government and its scientists. We look forward to doing all we can to help the UK going forward in 2021.”
Health Secretary Matt Hancock
said: “It is excellent to be working with a UK firm to deliver millions of these rapid tests, which are being deployed across the country to help protect our communities and most vital public services. Roughly one in three people with Covid-19 don’t display symptoms. This is why asymptomatic testing is so crucial in our fight against the virus, and why I’m so grateful to see the British diagnostics industry use their ingenuity and expertise in our shared purpose to protect our communities.” Baroness Dido Harding, interim
executive chairwoman of the National Institute for Health Protection, said: “I am really pleased that we have been able to work with SureScreen to ensure we have a British supplier for this vital testing technology. Lateral Flow Tests are playing an ever- increasing role in our testing programme as we continue to expand testing to find positive cases among those without symptoms. Having a British manufacturer provides greater certainty that we will be able to continue to grow our supply of these important tests.”
business network February 2021
11
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92
